High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers - Archive ouverte HAL
Article Dans Une Revue Brachytherapy Année : 2019

High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers

Résumé

The purpose of this study was to analyze and compare clinical outcomes of low-dose-rate (LDR) and high-dose-rate (HDR) interstitial brachytherapy boost (ISBT) after EBRT or radio chemotherapy for the treatment of anal canal cancers.

Domaines

Sciences du Vivant [q-bio] Biologie cellulaire

Ghislain Bidaut  : Connectez-vous pour contacter le contributeur

https://hal.science/hal-02533391

Soumis le : lundi 6 avril 2020-14:03:30

Dernière modification le : lundi 2 septembre 2024-15:12:34

Fichier non déposé

Dates et versions

hal-02533391 , version 1 (06-04-2020)

Identifiants

Citer

Leonel Varela Cagetti, Christophe Zemmour, Naji Salem, Mathieu Minsat, Marjorie Ferré, et al.. High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers. Brachytherapy, 2019, 18 (6), pp.814-822. ⟨10.1016/j.brachy.2019.08.005⟩. ⟨hal-02533391⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM CNRS UNIV-AMU FNCLCC CURIE PAOLI_CALMETTES PSL U1252 CRCM MEMO-SHS
57 Consultations
0 Téléchargements

Altmetric

Partager

More